JB Chemicals & Pharmaceuticals Ltd, in which private equity giant KKR agreed to acquire a controlling stake earlier this year, has roped in an executive from drugmaker Cipla Ltd for its top post. Nikhil Chopra, 47, has been appointed as CEO and whole-time director. JB Chemicals said in a stock market disclosure ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.